Nuclear receptors as molecular targets for cardiometabolic and central nervous system diseases:
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
Birmingham [u.a.]
Ios Press
2008
|
Schriftenreihe: | Solvay Pharmaceuticals Conferences
8 |
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | 117 S. |
ISBN: | 9781586038571 |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV035056161 | ||
003 | DE-604 | ||
005 | 20081027 | ||
007 | t | ||
008 | 080917s2008 |||| 00||| eng d | ||
020 | |a 9781586038571 |9 978-1-58603-857-1 | ||
020 | |z 1586038575 |9 1-58603-857-5 | ||
035 | |a (OCoLC)301798002 | ||
035 | |a (DE-599)BVBBV035056161 | ||
040 | |a DE-604 |b ger |e rakwb | ||
041 | 0 | |a eng | |
049 | |a DE-12 | ||
245 | 1 | 0 | |a Nuclear receptors as molecular targets for cardiometabolic and central nervous system diseases |
264 | 1 | |a Birmingham [u.a.] |b Ios Press |c 2008 | |
300 | |a 117 S. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a Solvay Pharmaceuticals Conferences |v 8 | |
650 | 0 | 7 | |a Kernrezeptor |0 (DE-588)4635996-5 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Krankheit |0 (DE-588)4032844-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Targeted drug delivery |0 (DE-588)4302415-4 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Kardiovaskuläre Krankheit |0 (DE-588)4024666-8 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Zentralnervensystem |0 (DE-588)4067637-7 |2 gnd |9 rswk-swf |
651 | 7 | |a Nizza |0 (DE-588)4075416-9 |2 gnd |9 rswk-swf | |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
689 | 0 | 0 | |a Kardiovaskuläre Krankheit |0 (DE-588)4024666-8 |D s |
689 | 0 | 1 | |a Kernrezeptor |0 (DE-588)4635996-5 |D s |
689 | 0 | 2 | |a Targeted drug delivery |0 (DE-588)4302415-4 |D s |
689 | 0 | 3 | |a Nizza |0 (DE-588)4075416-9 |D g |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Zentralnervensystem |0 (DE-588)4067637-7 |D s |
689 | 1 | 1 | |a Krankheit |0 (DE-588)4032844-2 |D s |
689 | 1 | 2 | |a Kernrezeptor |0 (DE-588)4635996-5 |D s |
689 | 1 | 3 | |a Targeted drug delivery |0 (DE-588)4302415-4 |D s |
689 | 1 | 4 | |a Nizza |0 (DE-588)4075416-9 |D g |
689 | 1 | |C b |5 DE-604 | |
700 | 1 | |a Junien, Jean Louis |e Sonstige |4 oth | |
830 | 0 | |a Solvay Pharmaceuticals Conferences |v 8 |w (DE-604)BV022472515 |9 8 | |
856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016724751&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-016724751 |
Datensatz im Suchindex
_version_ | 1807322168270258176 |
---|---|
adam_text |
Titel: Nuclear receptors as molecular targets for cardiometabolic and central nervous system diseases
Autor: Junien, Jean Louis
Jahr: 2008
ix
Contents
Preface v
W. Cautreels, C. Steinborn and L. Turski
List of Contributors vii
Conference Preface and Keynote Lecture
Conference Preface 3
Bart Staels and Jean Louis Junien
Keynote Lecture - An Introduction to the Nuclear Receptor Superfamily 5
Vincent Laudet
Metabolic Control by LXR 19
Jean Louis Junien
Regulation of Cardiac Energetic by the Orphan Nuclear Receptors ERRa and y 33
Vincent Giguere
FXR and Bile Acids: Critical Modulators of Metabolism 43
Peter A. Edwards and Yanqiao Zhang
The Role of PPARs in Human Prediabetes 51
HaraldStaiger, Claus Thamer and Hans-Ulrich Haring
New Insights in the Role of the Intestine in Reverse Cholesterol Transport 61
Folkert Kuipers
NR4A Nuclear Receptors in the Vessel Wall 75
Claudia M. van Tiel and Car lie J.M. de Vries
Cholesterol: Novel Target in the Treatment of Alzheimer's Disease? 85
M. Mulder
PPARy-Mediated Effects in CNS Disorders 93
StephanA. Paxian, Lars Tatenhorst and Michael T. Heneka
Molecular Biology of Circadian Rhythms and Cardiometabolic Disease: Role
of the Orphan Nuclear Receptor Rev-erba 109
Bart Staels and Helene Duez
Author Index 117 |
adam_txt |
Titel: Nuclear receptors as molecular targets for cardiometabolic and central nervous system diseases
Autor: Junien, Jean Louis
Jahr: 2008
ix
Contents
Preface v
W. Cautreels, C. Steinborn and L. Turski
List of Contributors vii
Conference Preface and Keynote Lecture
Conference Preface 3
Bart Staels and Jean Louis Junien
Keynote Lecture - An Introduction to the Nuclear Receptor Superfamily 5
Vincent Laudet
Metabolic Control by LXR 19
Jean Louis Junien
Regulation of Cardiac Energetic by the Orphan Nuclear Receptors ERRa and y 33
Vincent Giguere
FXR and Bile Acids: Critical Modulators of Metabolism 43
Peter A. Edwards and Yanqiao Zhang
The Role of PPARs in Human Prediabetes 51
HaraldStaiger, Claus Thamer and Hans-Ulrich Haring
New Insights in the Role of the Intestine in Reverse Cholesterol Transport 61
Folkert Kuipers
NR4A Nuclear Receptors in the Vessel Wall 75
Claudia M. van Tiel and Car lie J.M. de Vries
Cholesterol: Novel Target in the Treatment of Alzheimer's Disease? 85
M. Mulder
PPARy-Mediated Effects in CNS Disorders 93
StephanA. Paxian, Lars Tatenhorst and Michael T. Heneka
Molecular Biology of Circadian Rhythms and Cardiometabolic Disease: Role
of the Orphan Nuclear Receptor Rev-erba 109
Bart Staels and Helene Duez
Author Index 117 |
any_adam_object | 1 |
any_adam_object_boolean | 1 |
building | Verbundindex |
bvnumber | BV035056161 |
ctrlnum | (OCoLC)301798002 (DE-599)BVBBV035056161 |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 cb4500</leader><controlfield tag="001">BV035056161</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20081027</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">080917s2008 |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781586038571</subfield><subfield code="9">978-1-58603-857-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">1586038575</subfield><subfield code="9">1-58603-857-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)301798002</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV035056161</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Nuclear receptors as molecular targets for cardiometabolic and central nervous system diseases</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Birmingham [u.a.]</subfield><subfield code="b">Ios Press</subfield><subfield code="c">2008</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">117 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Solvay Pharmaceuticals Conferences</subfield><subfield code="v">8</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kernrezeptor</subfield><subfield code="0">(DE-588)4635996-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krankheit</subfield><subfield code="0">(DE-588)4032844-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Targeted drug delivery</subfield><subfield code="0">(DE-588)4302415-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kardiovaskuläre Krankheit</subfield><subfield code="0">(DE-588)4024666-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Zentralnervensystem</subfield><subfield code="0">(DE-588)4067637-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Nizza</subfield><subfield code="0">(DE-588)4075416-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Kardiovaskuläre Krankheit</subfield><subfield code="0">(DE-588)4024666-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Kernrezeptor</subfield><subfield code="0">(DE-588)4635996-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Targeted drug delivery</subfield><subfield code="0">(DE-588)4302415-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Nizza</subfield><subfield code="0">(DE-588)4075416-9</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Zentralnervensystem</subfield><subfield code="0">(DE-588)4067637-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Krankheit</subfield><subfield code="0">(DE-588)4032844-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Kernrezeptor</subfield><subfield code="0">(DE-588)4635996-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="3"><subfield code="a">Targeted drug delivery</subfield><subfield code="0">(DE-588)4302415-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="4"><subfield code="a">Nizza</subfield><subfield code="0">(DE-588)4075416-9</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="C">b</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Junien, Jean Louis</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Solvay Pharmaceuticals Conferences</subfield><subfield code="v">8</subfield><subfield code="w">(DE-604)BV022472515</subfield><subfield code="9">8</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016724751&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-016724751</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift gnd-content |
genre_facet | Konferenzschrift |
geographic | Nizza (DE-588)4075416-9 gnd |
geographic_facet | Nizza |
id | DE-604.BV035056161 |
illustrated | Not Illustrated |
index_date | 2024-07-02T21:58:33Z |
indexdate | 2024-08-14T00:52:12Z |
institution | BVB |
isbn | 9781586038571 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-016724751 |
oclc_num | 301798002 |
open_access_boolean | |
owner | DE-12 |
owner_facet | DE-12 |
physical | 117 S. |
publishDate | 2008 |
publishDateSearch | 2008 |
publishDateSort | 2008 |
publisher | Ios Press |
record_format | marc |
series | Solvay Pharmaceuticals Conferences |
series2 | Solvay Pharmaceuticals Conferences |
spelling | Nuclear receptors as molecular targets for cardiometabolic and central nervous system diseases Birmingham [u.a.] Ios Press 2008 117 S. txt rdacontent n rdamedia nc rdacarrier Solvay Pharmaceuticals Conferences 8 Kernrezeptor (DE-588)4635996-5 gnd rswk-swf Krankheit (DE-588)4032844-2 gnd rswk-swf Targeted drug delivery (DE-588)4302415-4 gnd rswk-swf Kardiovaskuläre Krankheit (DE-588)4024666-8 gnd rswk-swf Zentralnervensystem (DE-588)4067637-7 gnd rswk-swf Nizza (DE-588)4075416-9 gnd rswk-swf (DE-588)1071861417 Konferenzschrift gnd-content Kardiovaskuläre Krankheit (DE-588)4024666-8 s Kernrezeptor (DE-588)4635996-5 s Targeted drug delivery (DE-588)4302415-4 s Nizza (DE-588)4075416-9 g DE-604 Zentralnervensystem (DE-588)4067637-7 s Krankheit (DE-588)4032844-2 s b DE-604 Junien, Jean Louis Sonstige oth Solvay Pharmaceuticals Conferences 8 (DE-604)BV022472515 8 HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016724751&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Nuclear receptors as molecular targets for cardiometabolic and central nervous system diseases Solvay Pharmaceuticals Conferences Kernrezeptor (DE-588)4635996-5 gnd Krankheit (DE-588)4032844-2 gnd Targeted drug delivery (DE-588)4302415-4 gnd Kardiovaskuläre Krankheit (DE-588)4024666-8 gnd Zentralnervensystem (DE-588)4067637-7 gnd |
subject_GND | (DE-588)4635996-5 (DE-588)4032844-2 (DE-588)4302415-4 (DE-588)4024666-8 (DE-588)4067637-7 (DE-588)4075416-9 (DE-588)1071861417 |
title | Nuclear receptors as molecular targets for cardiometabolic and central nervous system diseases |
title_auth | Nuclear receptors as molecular targets for cardiometabolic and central nervous system diseases |
title_exact_search | Nuclear receptors as molecular targets for cardiometabolic and central nervous system diseases |
title_exact_search_txtP | Nuclear receptors as molecular targets for cardiometabolic and central nervous system diseases |
title_full | Nuclear receptors as molecular targets for cardiometabolic and central nervous system diseases |
title_fullStr | Nuclear receptors as molecular targets for cardiometabolic and central nervous system diseases |
title_full_unstemmed | Nuclear receptors as molecular targets for cardiometabolic and central nervous system diseases |
title_short | Nuclear receptors as molecular targets for cardiometabolic and central nervous system diseases |
title_sort | nuclear receptors as molecular targets for cardiometabolic and central nervous system diseases |
topic | Kernrezeptor (DE-588)4635996-5 gnd Krankheit (DE-588)4032844-2 gnd Targeted drug delivery (DE-588)4302415-4 gnd Kardiovaskuläre Krankheit (DE-588)4024666-8 gnd Zentralnervensystem (DE-588)4067637-7 gnd |
topic_facet | Kernrezeptor Krankheit Targeted drug delivery Kardiovaskuläre Krankheit Zentralnervensystem Nizza Konferenzschrift |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016724751&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
volume_link | (DE-604)BV022472515 |
work_keys_str_mv | AT junienjeanlouis nuclearreceptorsasmoleculartargetsforcardiometabolicandcentralnervoussystemdiseases |